Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wasserman

Showing results (281-290 of 313) with videos related to

Pageof 32
Sort By:
The American Journal of Cardiology|June 26, 2001
Elevated plasma tissue plasminogen activator and anti-THP-1 antibodies are independently associated with decreased graft survival in cardiac transplant recipientsM K Warshofsky, M Dominguez, M S Eisenberg, et al.
Human Vaccines|August 2, 2008
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adultsWellington Sun, Dennis Cunningham, Steven S Wasserman, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
MRCKα represses GEF-H1 mediated RhoA activation to promote ovarian cancer spheroid growth and invasionAasiya Remtulla, Alison M Kurimchak, Alicia Canuel, et al.
Lancet (London, England)|November 22, 2001
Determinants of HIV-1 shedding in the genital tract of womenA Kovacs, S S Wasserman, D Burns, et al.
Vaccine|April 1, 1995
Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2K L Kotloff, G A Losonsky, J P Nataro, et al.
Vaccine|November 27, 2002
Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoitesRobert Edelman, Steven S Wasserman, James G Kublin, et al.
Infection and Immunity|September 1, 1997
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and PeruD N Taylor, C O Tacket, G Losonsky, et al.
Infection and Immunity|November 24, 1999
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccinationC O Tacket, M B Cohen, S S Wasserman, et al.
Research Square|May 20, 2024
Derivation of human primary prostate epithelial cell lines by differentially targeting the <i>CDKN2A</i> locus along with expression of hTERTJason S Wasserman, Holly Fowle, Rumesa Hashmi, et al.
Journal of the American College of Cardiology|December 6, 2005
Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical TrialTed Feldman, Hal S Wasserman, Howard C Herrmann, et al.
Pageof 32

Showing results (281-290 of 313) with videos related to

Sort By:
Pageof 32
The American Journal of Cardiology|June 26, 2001
Elevated plasma tissue plasminogen activator and anti-THP-1 antibodies are independently associated with decreased graft survival in cardiac transplant recipientsM K Warshofsky, M Dominguez, M S Eisenberg, et al.
Human Vaccines|August 2, 2008
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adultsWellington Sun, Dennis Cunningham, Steven S Wasserman, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
MRCKα represses GEF-H1 mediated RhoA activation to promote ovarian cancer spheroid growth and invasionAasiya Remtulla, Alison M Kurimchak, Alicia Canuel, et al.
Lancet (London, England)|November 22, 2001
Determinants of HIV-1 shedding in the genital tract of womenA Kovacs, S S Wasserman, D Burns, et al.
Vaccine|April 1, 1995
Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2K L Kotloff, G A Losonsky, J P Nataro, et al.
Vaccine|November 27, 2002
Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoitesRobert Edelman, Steven S Wasserman, James G Kublin, et al.
Infection and Immunity|September 1, 1997
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and PeruD N Taylor, C O Tacket, G Losonsky, et al.
Infection and Immunity|November 24, 1999
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccinationC O Tacket, M B Cohen, S S Wasserman, et al.
Research Square|May 20, 2024
Derivation of human primary prostate epithelial cell lines by differentially targeting the <i>CDKN2A</i> locus along with expression of hTERTJason S Wasserman, Holly Fowle, Rumesa Hashmi, et al.
Journal of the American College of Cardiology|December 6, 2005
Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical TrialTed Feldman, Hal S Wasserman, Howard C Herrmann, et al.
Pageof 32